AI is rapidly transforming how clinical trials are designed, run, [...]
Peer-reviewed paper highlights pain-free enzymatic approach for venous leg ulcers [...]
Peer-reviewed trial results demonstrate robust bacterial reduction without resistance in [...]
Qureight’s deep-learning biomarkers confirm representativeness of Insilico’s Phase 2a IPF [...]
OMED Health, a UK-based company developing non-invasive breath analysis tools [...]
Nanoscope Therapeutics begins FDA submission for gene-agnostic therapy to treat retinitis pigmentosa
Nanoscope Therapeutics has initiated a rolling submission for its Biologics [...]
NICE recommends Mirikizumab for moderately to severely active Crohn’s Disease after biologic failure
Mirikizumab is now recommended by NICE for routine NHS use [...]
SPT Labtech has partnered with Semarion to integrate its firefly [...]
As healthcare delivery evolves – especially in rural and underserved [...]
VIVES Partners, managing company of VIVES Funds, has joined a [...]